Replies to post #2374 on RespireRx Pharmaceuticals Inc (RSPI)

[DewDiligence]

>Pfizer has lost a lot of their pipeline recently - Indiplon (NBIX), Asenapine (Organon), and now Torcetrapib<

And Macugen might as well be considered dead ($9M in 3Q06 sales).